DSC
MBOT icon

Duncker Streett & Co’s Microbot Medical MBOT Stock Holding History

Duncker Streett & Co’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8
Closed – – 575
2018
Q3 		$0 Buy
8
+1
+14% +$9 ﹤0.01% 593
2018
Q2 		$0 Hold
7
– – ﹤0.01% 604
2018
Q1 		$0 Hold
7
– – ﹤0.01% 600
2017
Q4 		$0 Hold
7
– – ﹤0.01% 607
2017
Q3 		$0 Hold
7
– – ﹤0.01% 610
2017
Q2 		$0 Hold
7
– – ﹤0.01% 622
2017
Q1 		$1K Hold
7
– – ﹤0.01% 615
2016
Q4 		$1K Hold
7
– – ﹤0.01% 610
2016
Q3 		$1K Buy
+7
New +$913 ﹤0.01% 601

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Duncker Streett & Co's MBOT Position: Q4 2018 in Review

Duncker Streett & Co sold out of Microbot Medical (MBOT) in Q4 2018, closing a stake of 8 shares.

Duncker Streett & Co first reported a position in MBOT in Q3 2016 and held it in 9 quarters. The position peaked at $1K in Q1 2017. 29 funds tracked by Wall St. Rank hold MBOT as of Q4 2018.

  • Duncker Streett & Co reported no remaining Microbot Medical position as of Q4 2018 after selling out during the quarter.
  • Duncker Streett & Co sold 8 Microbot Medical shares in Q4 2018.
  • Duncker Streett & Co first reported a position in Microbot Medical in Q3 2016 and held it in 9 quarters.
  • Duncker Streett & Co's Microbot Medical position peaked at $1K in Q1 2017.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2018.

Based on Duncker Streett & Co's 13F filing for Q4 2018, filed 24 Jan 2019.